Crossmark

Clinical and genetic profiles of patients with hereditary and wild-type transthyretin amyloidosis: the Transthyretin Cardiac Amyloidosis Registry in the state of São Paulo, Brazil (REACT-SP)

Crossref DOI link: https://doi.org/10.1186/s13023-024-03281-z

Published Online: 2024-07-20

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Fernandes, Fábio http://orcid.org/0000-0002-9323-8805
Luzuriaga, Georgina del Cisne Jadán http://orcid.org/0000-0002-6000-1297
da Fonseca, Guilherme Wesley Peixoto http://orcid.org/0000-0001-6477-8741
Correia, Edileide Barros

Carvalho, Alzira Alves Siqueira

Macedo, Ariane Vieira Scarlatelli

Coelho-Filho, Otavio Rizzi

Scheinberg, Phillip

Antunes, Murillo Oliveira

Schwartzmann, Pedro Vellosa

Mangini, Sandrigo

Marques, Wilson

Simões, Marcus Vinicius
Funding

Funding for this research was provided by:

Pfizer Foundation (68322757)
License Information

Text and Data Mining valid from 2024-07-20

Version of Record valid from 2024-07-20
More Information

Article History

Received: 14 March 2024

Accepted: 3 July 2024

First Online: 20 July 2024

Declarations

:

: HCFMUSP Ethics Committee approved this study, and written informed consent was waived. (CAAE: 53302721.5.1001.0068; Approval report No. 5.188.324).

: Not applicable.

: The authors declare no conflicts of interest to disclose.

Document is current

Any future updates will be listed below